World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Apr 04
Home tests could be key to curb HIV spread
Making self-testing kits for HIV widely available could help reduce the global epidemic of AIDS, according to a new study led by an Indian-origin scientist.


The research which analysed data from many countries, including India, shows HIV self-testing removes much of the fear and stigma associated with being tested for the deadly disease.

The study by Dr Nitika Pant Pai from The Research Institute of the McGill University Health Centre (RI-MUHC) is the first of its kind and could pave the way for early detection and treatment around the world, thereby reducing transmission.


"Thirty years into the HIV epidemic, there is no vaccine in sight. Treatment as a prevention strategy has been known to work, but uptake of HIV screening seems to be limited by a societal problem: HIV stigma and perceived discrimination," said Pant Pai, first author of the study.


According to UNAIDS, 50 per cent of people living with HIV worldwide are unaware of their HIV status and about 2.5 million people become infected every year.


Pant Pai believes that access to an HIV self-test linked to expedited counselling systems will help expand access to screening and reduce judgement and perceived attitudes around HIV testing.


Self-tests are performed in oral fluid samples from the gum lining of the mouth in the privacy of one`s home. They are non-invasive, convenient, ensure confidentiality and can provide results within 20 minutes.


The results are self-interpreted however, and require confirmation at a medical clinic if positive.


Several studies have been conducted to determine the best methods of making a self-test with linked counselling and referral services available in various African, North American and European settings.


Pant Pai and her colleagues decided to look at the global evidence on self-testing strategies based on acceptability, feasibility and accuracy and success with linkages to care.


They examined 21 worldwide studies and found that two distinct self-testing strategies have been tried: supervised self-testing, and unsupervised self-testing.


Most of the data came from studies carried out in high-income settings including the US, Canada, Spain and the Netherlands, as well as Kenya, Singapore, Malawi and India.


Across the various studies, researchers observed that acceptability was very high for both self-testing strategies.


They also found evidence that people preferred self-testing to facility-based testing and oral self-testing to blood-based self-testing.


"The preference was largely driven by the fact the oral self-tests are non-invasive, convenient, easy to swab and do not involve a finger stick or blood from your arm for a preliminary screen," said Pant Pai in the study published in PLoS Medicine journal.

Apr 04
Cholesterol lowering eye drops 'may fight sight loss'
A new study led by an Indian origin scientist suggests that eye drops designed to lower cholesterol may be able to save sight in some people with a common cause of age-related vision loss.

The study, which was supported by the National Institutes of Health, showed that large cells called macrophages appear to play a key role in clearing cholesterol from the eye, and that with aging, these cells become less efficient at this task.


Eye drops containing a type of drug known to promote cholesterol release from macrophages, called a liver X receptor (LXR) agonist, helped restore macrophage function and prevent AMD progression in a mouse model.


The study was led by Rajendra Apte, M.D., Ph.D., a professor of ophthalmology and vision sciences at Washington University in St. Louis.

AMD causes damage to the macula, a region of the retina responsible for central, high-resolution vision. The macula is dense with light-sensing cells called photoreceptors, and is what humans rely on for tasks that require sharp vision, such as reading, driving, and recognizing faces.


This sharp vision deteriorates in AMD, which can take two forms. In one, sometimes referred to as dry AMD, vision loss is due to a gradual loss of photoreceptors in the macula. In the other, referred to as wet or neovascular AMD, abnormal blood vessels grow under the macula, leaking blood and causing rapid damage to the photoreceptors.


"This study points to a novel strategy for early intervention to prevent the progression of AMD to the severe neovascular form of the disease," said Grace Shen, Ph.D., a program director at NIH`s National Eye Institute, which funded the research.


Macrophages, literally "big eaters" in Greek, act like garbage collectors. They scavenge for debris, engulf it, and process it.

In previous studies, Dr. Apte found that macrophages normally help limit the growth of new blood vessels in the eye, but with age, the cells lose this ability. The new study suggests that prior to these changes, old macrophages become less efficient at processing cholesterol.

A protein called ABCA1 is needed for macrophages to release cholesterol into the bloodstream. In these experiments on mice, Dr. Apte and his team found that in old macrophages, there is a decrease in the level of ABCA1 protein. The researchers found a similar drop in ABCA1 levels in blood cells-the source of macrophages-in samples donated by older people (ages 67-87) vs. younger ones (ages 25-34). The ABCA1 gene has been identified as a risk factor for AMD.

To investigate the link between these changes and blood vessel growth, the researchers first performed tests in cell culture. When grown in a dish with blood vessel cells, young macrophages efficiently stopped the cells from multiplying, but old macrophages did not. Deleting the ABCA1 gene in young macrophages caused them to behave like old macrophages.


Next, the researchers tried treating old macrophages with an LXR agonist; these drugs are known to enhance cholesterol transport from macrophages by turning on the ABCA1 gene. Exposure to the drug rejuvenated the old macrophages and enabled them to inhibit blood vessel cell growth.


The researchers also tested the LXR agonist in mice with an eye injury that produces abnormal blood vessel growth, similar to that seen in neovascular AMD. Eye drops of the drug significantly reduced this blood vessel growth when given several days before the injury.


The study was published in Cell Metabolism.

Apr 03
Bowel cancer rates on rise among men
Bowel cancer rates have increased by 29 percent among men but only by about six percent among women in the past 35 years, a report by Cancer Research UK has claimed.

The figures also showed that the raise is particularly severe among people in their 60s and 70s, who account for more than 23,000 cases every year, the Telegraph reported.

Doctors though baffled by the increase of the cancer in this particular age group, and the disparity between men and women, said that risk factors for the disease include diet, weight, physical exercise, drinking and smoking.

The report was released to mark a new awareness and fundraising campaign in the name of English footie ace Bobby Moore , the World Cup winning captain who died from the disease in 1993, aged 51.

The report further showed that bowel cancer cases have increased from 45 per 100,000 men in 1975-77 to 58 cases in 2008-10, equalling to a rise of almost 33 percent.

In contrast, the charity said that the rates among women were risen from 35 cases per 100,000 to 37 cases over the same period.

Prof Matthew Seymour, director of the National Cancer Research Network, said they know that the bowel cancer risk increases as people age and, since everyone is living longer, it is no surprise to see that the number of people getting afflicted with the disease is on the rise.
He said but when they looked at these figures and took people`s age into account, they still see that the bowel cancer risk has gone up in men in the last 35 years.

Apr 03
Drug for erectile disorder could treat obesity
Although best known for promoting erections, sildenafil may also serve as a weight loss aid by coaxing our bodies to store more healthy "brown fat" relative to unhealthy "white fat" than it would otherwise do on its own, a new study suggests.

According to the research, this is because sildenafil inhibits the breakdown of cyclic GMP, which has been well known as a messenger molecule used by the body to control blood pressure and flow, and has now been shown to play an important role determining which type of fat-white or brown-the body stores.

"There is a growing need for novel treatments against obesity," Alexander Pfeifer, M.D., Ph.D., a researcher involved in the work from the Institute of Pharmacology and Toxicology at the University of Bonn, Biomedical Center in Bonn, Germany said.

"Finding new positive effects of existing drugs, such as sildenafil, in adipose tissue might help to bridge the period until novel drugs against obesity have been developed," he said.

To make this discovery, Pfeifer and colleagues used mice to show that cyclic GMP reduced the secretion of pro-inflammatory hormones, which, in turn, shifted the "color code" of fat from white to brown.

Mice treated with sildenafil showed browning of the white fat after just a few days of treatment, which is believed to be the result of high cyclic GMP levels.

Then the researchers used isolated fat cells and treated the cells directly with cyclic GMP and identified a "browning" effect as well.
The study is published online in The FASEB Journal.

Apr 02
Pneumonia could now be stopped in its tracks
Scientists have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia.

Pneumonia and other infections sometimes provoke an inflammatory response from the body that is more detrimental than the disease-causing bacteria, said senior author Rama Mallampalli, M.D, professor and vice chair for research, Department of Medicine, and director of the Acute Lung Injury Center of Excellence at the University of Pittsburgh School of Medicine.

"In our ongoing studies of pneumonia, we found infecting bacteria activate a previously unknown protein called Fbxo3 to form a complex that degrades another protein called Fbxl2, which is needed to suppress the inflammatory response," said Dr. Mallampalli, who is also chief of the pulmonary division of the VA Pittsburgh Healthcare System.

"The result is an exaggerated inflammatory response that can lead to further damage of the lung tissue, multi-organ failure and shock," he added.

The research team, led by Bill B. Chen, Ph.D., associate professor, Division of Pulmonary, Allergy and Critical Care Medicine, conducted experiments in which mice that lacked the ability to make Fbxo3 were infected with a strain of Pseudomonas bacteria, and found that they had better lung mechanics and longer survival than mice that still made the protein.

Research team members Bryan J. McVerry, M.D., and Yingze Zhang, Ph.D., both of the Acute Lung Injury Center of Excellence, found that blood samples from 16 people who had sepsis, a condition of systemic inflammation, revealed higher levels of Fbxo3 and other inflammatory proteins and lower levels of Fbxl2 than samples from seven patients who did not have sepsis or lung infection.

Based on the structure of Fbxo3, the researchers developed a family of small molecules with the aim of inhibiting its activity. Administration of one of them, called BC-1215, led to reduced inflammatory markers and improved lung mechanics in mouse models of pneumonia and sepsis.

"The key is to find ways to help the body temper its inflammatory response so that it's able to kill the infectious agent without causing injury to healthy tissue," Dr. Mallampalli said.

"The F-box protein Fbxo3, and other related proteins, represent ideal targets for treatment of acute lung injury, because it controls the innate immune response, is upstream of important inflammatory signaling pathways, and is more selective than traditional drugs that regulate protein turnover," noted Mark T. Gladwin, M.D., chief of the Division of Pulmonary, Allergy and Critical Care Medicine, Pitt School of Medicine.
The team is beginning to study the effects of BC-125 on other conditions of systemic inflammation, such as colitis and arthritis.

They reported their findings today in Nature Immunology.

Apr 02
Eating in front of TV can make you put on weight
Eating while watching television or working at a desk could lead to excess weight gain, according to a new study, because people are not aware of how much they have eaten.

By contrast, researchers found that remembering previous meals that were delicious and filling can lead to us eating smaller portions and ultimately enjoying trimmer waistlines.

Techniques such as writing down previous meals and using visual reminders of previous meals, such as keeping food wrappers were found to help with awareness of comsumption and lead to a reduction in meal sizes.

Lead researcher Dr Eric Robinson, from the Institute of Psychology, Health and Society based at Liverpool University, said if people recalled their last meal as being filling and satisfying then they ate less during their next meal.

He added that this could be developed as a new strategy to help with weight loss and maintenance and reduce the need for calorie controlled dieting.

The findings were published in the American Journal of Clinical Nutrition.

Apr 01
Cut salt intake, exercise to avoid high BP
Shruti Jain was a busy working mother juggling children, work and household chores with aplomb, until she suddenly collapsed in office one day. Diagnosed with a stroke, she had to undergo a six-month recuperation and paid a hefty fee at a private hospital.

Little did the 35-year-old marketing executive know that she had been suffering from hypertension, which had gone undetected for a long time, ultimately leading to the stroke she suffered.

Going by the lifestyles most of us lead, doctors say hypertension or high blood pressure (BP) can affect any of us and should be taken seriously as it is a silent killer.

"A lot of Indians fall into the pre-hypertension category where they think they are absolutely fine and don`t pay attention to their rising blood pressure," Ravi Kasliwal, chairman of the division of clinical and prevention cardio diseases at Medanta - The Medicity Hospital in Gurgaon, adjoining Delhi, told IANS.

According to the World Health Organisation (WHO), high BP affects every third person above the age of 18 years.

Given the seriousness of the problem, WHO has selected hypertension as its theme for 2013, with special focus on it on World Health Day on April 7.

Blaming Indian food habits and a sedantary lifestyle, Kasliwal said: "Most of us grab snacks like namkeens and samosas when hungry between meals. Not only do these have a high salt content but they are also sources of trans-fats."

Experts estimate that the number of patients in India with high BP is likely to rise from about 140 million in 2008 to nearly 215 million by 2030 along with an increase in the risk of complications such as heart attacks, strokes, kidney problems and other serious illnesses.

The problem is further compounded as high BP is a silent killer because it can remain undetected and manifest years later as a serious heart problem, say doctors.

In India, experts say a large number of people are in the pre-hypertension category - BP of 130/90 against the normal range of 120/90. People with BP of above 140/90 are considered to be in the hypertension category.

High BP, as of today, remains inadequately controlled in India as a large number of cases go undetected.

"The incidence of high blood pressure ranges from 20 to 39 percent in urban areas and 12 to 17 percent in rural areas," says Sailesh Mohan, senior research scientist and associate professor in the Public Health Foundation of India (PHFI).

PHFI is a public-private initiative that works on promoting health issues.
High BP is, however, both preventable and treatable.

For many people, lifestyle changes such as cutting down on salt; eating a balanced diet; avoiding harmful use of alcohol; getting regular exercise; and avoiding tobacco use are sufficient to control blood pressure.

For others, medication is required, which is effective when taken as prescribed.

Rohit Sobti, a physician with regional medical services in the WHO, said it is easy to prevent the problem if people just control their diet and change their lifestyle.

"Merely controlling dietary and lifestyle regime can easily avert any complications arising out of high blood pressure. It is important to get BP checked on a regular basis and avoid self-medication," Sobti told IANS.

Kasliwal said a simple measure like restricting the salt intake per person to less than five grams per day and half an hour of exercise can help control hypertension that is assuming epic proportions in the country.

He also said that coronary as well as cerebral strokes and also dementia in old age can be a direct result of high blood pressure.

One of the voluntary targets proposed by WHO and likely to be approved by the World Health Assembly in May this year is to achieve a 30 per cent reduction in average salt consumption by 2025 from the consumption level in the year 2010.

There were nine global targets, which may be adopted. These included reducing deaths due to hypertension by 25 percent by 2025, encouraging physical activity and avoiding tobacco, Sobti said.

"Unhealthy lifestyles are killing people," said Renu Garg, regional advisor in non-communicable disease, WHO regional office for South-East Asia.

"Most of us lead a sedantary lifestyle, eat unhealthy food and don`t exercise. Indians urgently need to take measures like reducing salt intake, exercising and avoiding tobacco and excessive alcohol," Garg added.

Apr 01
HRT linked to higher risk of contracting and dying from breast cancer
Estrogen plus progestin use has been linked with increased breast cancer incidence, a study has found.

The study also found that prognosis is similar for combined hormone therapy`s users and nonusers, suggesting that death from breast cancer may be higher for hormone therapy users as well.

In the Women`s Health Initiative (WHI) randomized trial, estrogen plus progestin was associated with an increase in both breast cancer incidence and mortality.

In order to determine the differences between the WHI trial and other observational studies, Rowan T. Chlebowski, M.D., Ph.D., Los Angeles Biomedical Research Institute (LA BioMed) lead researcher and colleagues, looked at postmenopausal women, who had no prior hysterectomy with negative mammograms within two years and were either users or non-users of estrogen and progestin combined therapy.

They found that breast cancer incidence was higher in estrogen plus progestin users than incidence in nonusers.

Women who started hormone therapy closer to menopause had a higher breast cancer risk with a weakening influence as the time from menopause increased.

The researchers wrote that because survival after breast cancer diagnosis did not differ between estrogen plus progestin users and nonusers, the higher breast cancer incidence of those using estrogen plus progestin may lead to increased breast cancer mortality on a population basis.
The study has been published in the Journal of the National Cancer Institute.

Browse Archive